Government
medpagetoday.com posted a brief but concise article earlier this week on the issue of FDA regulating laboratory developed tests (LDTs). While the FDA has had the ability to regulate these tests since 1976, largely once regarded as "simple and...
Great news from Philips who announced on October 21st their completion of a glass versus digital concordance study to be submitted to FDA. The press release mentions 2,000 cases with approximately 16,000 reads. The press release goes on to...
The AP (10/3, Tanner) reports breast cancer patients are getting involved in a “big new project that aims to gather enormous troves of information about their diseases in hopes of finding new and better ways of treating patients like them –...
Young Survival Coalition Expresses Concern About Overlooked Moonsho...
I haven't written much about the President's Cancer Moonshot initiative recently and as much as I would like - perhaps because following some Blue Ribbon Panel recommendations and a large number of organizations and individuals expressing, in...
Last Fall I wrote a couple of posts about the growing disenchantment with 'Pinkification' and 'Pinktober' referencing the all-out blitz during October to go "Pink" for breast bancer awareness and prevention. In one of the pieces I mentioned...
Pathology 2.0 Comes of Age: Recommendations for Protecting Privacy ...
- Advocacy
- Anatomic Pathology
- Blogs
- Case of the Month
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Digital Pathology News
- Education
- File format
- General Healthcare News
- Government
- International
- Laboratory Compliance
- Laboratory Informatics
- Medical Research
- Microscopy
- Pathology News
- Patient Advocacy
- Personal
- Science
- TeleHealth
- Training
- Web/Tech
- Whole slide
There is an interesting article in this month's AMA Journal of Ethics by Drs. Crane and Gardner on the use of pathology images in social media. The authors introduce the article in their abstract as "There is a rising interest in the use of...